Atlas Trials

Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients

Clinical trial NCT02605213 · UNKNOWN

Trial details

NCT number
NCT02605213
Sponsor
Tehran University of Medical Sciences
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Primary Sclerosing Cholangitis
Start date
2015-09-01
Primary completion
2016-02-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.